Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Brewster

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Pharmacoepidemiology and Drug Safety|December 25, 2009
Early communication of drug safety concerns: a feasibility study on enhancing interaction between the pharmaceutical industry and regulatorsElizabeth Swain, Sarah Morgan, Wendy Brewster, et al.
Current Drug Safety|August 12, 2008
Evolving paradigms in pharmacovigilanceWendy Brewster, Trevor Gibbs, Karol Lacroix, et al.
Brachytherapy|October 8, 2021
Demographic and clinical factors associated with variations in opioid administration using conscious sedation during HDR brachytherapy for cervical cancerJessica M Wilson, Erik Davies, Xianming Tan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 28, 2022
Falls, walking or balance problems, and limitations in activities of daily living (ADLs) among older endometrial cancer survivorsChelsea Anderson, Andrew Olshan, Victoria Bae-Jump, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 24, 2011
Differentiating squamous cell carcinoma of the cervix and epithelioid trophoblastic tumorSara Jordan, Leslie M Randall, Yevgeniy Karamurzin, et al.
American Journal of Obstetrics and Gynecology|March 3, 2012
Discussion: 'Surgical staging in early ovarian carcinoma' by Garcia-Soto et alLinda Van Le, Amanda Jackson, Kevin Schuler, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 7, 2011
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal statusSteven J Skates, Phuong Mai, Nora K Horick, et al.
The Lancet. Oncology|February 25, 2012
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studiesCeleste Leigh Pearce, Claire Templeman, Mary Anne Rossing, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium studyJennifer A Doherty, Mary Anne Rossing, Kara L Cushing-Haugen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 10, 2008
Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white womenRachel T Palmieri, Melanie A Wilson, Edwin S Iversen, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Pharmacoepidemiology and Drug Safety|December 25, 2009
Early communication of drug safety concerns: a feasibility study on enhancing interaction between the pharmaceutical industry and regulatorsElizabeth Swain, Sarah Morgan, Wendy Brewster, et al.
Current Drug Safety|August 12, 2008
Evolving paradigms in pharmacovigilanceWendy Brewster, Trevor Gibbs, Karol Lacroix, et al.
Brachytherapy|October 8, 2021
Demographic and clinical factors associated with variations in opioid administration using conscious sedation during HDR brachytherapy for cervical cancerJessica M Wilson, Erik Davies, Xianming Tan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 28, 2022
Falls, walking or balance problems, and limitations in activities of daily living (ADLs) among older endometrial cancer survivorsChelsea Anderson, Andrew Olshan, Victoria Bae-Jump, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 24, 2011
Differentiating squamous cell carcinoma of the cervix and epithelioid trophoblastic tumorSara Jordan, Leslie M Randall, Yevgeniy Karamurzin, et al.
American Journal of Obstetrics and Gynecology|March 3, 2012
Discussion: 'Surgical staging in early ovarian carcinoma' by Garcia-Soto et alLinda Van Le, Amanda Jackson, Kevin Schuler, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 7, 2011
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal statusSteven J Skates, Phuong Mai, Nora K Horick, et al.
The Lancet. Oncology|February 25, 2012
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studiesCeleste Leigh Pearce, Claire Templeman, Mary Anne Rossing, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium studyJennifer A Doherty, Mary Anne Rossing, Kara L Cushing-Haugen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 10, 2008
Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white womenRachel T Palmieri, Melanie A Wilson, Edwin S Iversen, et al.
Pageof 2